The medication is still in the clinical trial process and is not approved by the FDA
Many patients describe feeling full sooner, needing smaller portions, or having quieter food noise persistent, intrusive thoughts about food reported by many patients with obesity
Semaglutide (Wegovy) FDA-approved for: Chronic weight management Treatment of Metabolic dysfunction-Associated Steatohepatitis (MASH) approved August 2025 FDA-indicated for: Reducing risk of heart attack, stroke, and cardiovascular death in adults with established cardiovascular disease who are obese or overweight Weekly injection Clinical trials show an average weight loss of 1215% of body weight
Gannon MC, Nuttall JA, Nuttall FQ
Customers expecting gradual brightening alongside a real skincare routine tend to stick around, and tend to be happier with what they see
And in giving you completely renewed lips, it exfoliates amazingly well